Genetics

📚 01 General Pediatrics • 🎯 101 High-Yield MCQs • Nelson 22nd Edition Standard

Fundamentals of Genetics & Sequence Variants

  • Single-Gene Disorders: : Characterized by a phenotype overwhelmingly determined by mutations affecting an individual gene ((GEN001)). - Distractors: Phenotypes determined by multiple genes represent polygenic/multifactorial disorders ((GEN001)).
  • Variable Expressivity: : Differences in clinical severity among individuals carrying the same pathogenic variant (e.g., GJB2 mutations causing mild to profound sensorineural hearing loss) ((GEN002)). - Distractors: Incomplete penetrance is the presence of a mutation without any clinical manifestations; pleiotropy involves one gene affecting multiple organ systems ((GEN002)).
  • Contiguous Gene Disorders: : Caused by chromosomal deletions involving two or more neighboring genes (e.g., DiGeorge syndrome via 22q11 deletion, presenting with conotruncal cardiac defects, thymic hypoplasia, and hypocalcemia) ((GEN003)). - Distractors: Marfan syndrome (FBN1), Cystic fibrosis (CFTR), and Duchenne muscular dystrophy (DMD) are single-gene disorders ((GEN003)).
  • Pathogenic Sequence Effects: : Deletions or insertions of nucleotide numbers not divisible by three cause a frameshift, altering the reading frame and typically introducing a premature stop codon leading to protein truncation and loss of function ((GEN009)). - Distractors: Synonymous (silent) substitutions, in-frame insertions (multiples of three), and splice-site substitutions generally do not alter the reading frame in this manner ((GEN009)).
  • Modifier Genes: : Independent genetic variants that alter the phenotype of a primary disorder (e.g., mannose-binding lectin gene variants worsening respiratory infections in cystic fibrosis) ((GEN010)). - Distractors: FBN1, CFTR, and DMD mutations are primary causal mutations, not modifiers ((GEN010)).
  • Digenic Inheritance: : Requires pathogenic variants in two separate genes together to express the phenotype (e.g., double heterozygotes in retinitis pigmentosa) ((GEN017)). - Distractors: Monogenic inheritance involves a single gene; pseudodominant inheritance mimics dominant patterns via recessive alleles ((GEN017)).
  • DNA Replication & Repair: : Replication errors and environmental damage are detected and corrected by DNA repair systems ((GEN008)). Telomerase acts specifically at telomeres ((GEN008)). ---

Cytogenetic & Molecular Diagnostic Techniques

  • Fluorescent In Situ Hybridization (FISH): : Uses fluorescent DNA probes to determine both the copy number (presence/absence) and the precise chromosomal location of a specific region ((GEN004)). Useful for microdeletion syndromes like DiGeorge syndrome (<5 Mb rearrangements) [GEN004, __35].
  • Chromosome Microarray Analysis (CMA): : Evaluates Copy Number Variations (CNVs) (deletions and duplications) involving one or more genes down to high resolutions [GEN022, __22]. - Technique: Array comparative genomic hybridization (aCGH) uses patient and normal reference DNA labeled with different fluorophores hybridized to microarray slides [__34]. - Rules: Does not require multiple family members (unlike linkage analysis) and cannot detect single-base substitutions ((GEN022)).
  • Next-Generation Sequencing (NGS): : Enables massive parallel sequencing of multiple genes, covering both coding and noncoding regions to detect single-nucleotide variants, indels, and structural alterations ((GEN023)).
  • Genetic Testing Validity: :
  • Analytical Validity: : Measures the accuracy with which a test detects or measures the presence of a specific pathogenic variant (laboratory precision and error rates) ((GEN024)). - Distractor: Clinical validity assesses how well the test predicts disease presence or clinical outcomes ((GEN024)). ---

Inheritance Patterns & Population Genetics

  • Autosomal Dominant: : Characterized by vertical transmission (parent-to-child) with a recurrence risk of 50% for each child regardless of sex ((GEN011)).
  • Autosomal Recessive: : Shows horizontal transmission (siblings affected in the same generation); both parents are typically heterozygous carriers with a 25% recurrence risk ((GEN012)). Examples include cystic fibrosis and sickle-cell disease ((GEN012)).
  • Pseudodominant Inheritance: : Apparent vertical transmission of an autosomal recessive disorder occurring when a homozygous affected individual mates with a heterozygous carrier (yielding 50% affected offspring) ((GEN014)).
  • X-Linked Inheritance: : Affected males transmit the mutant X chromosome to all daughters (carriers) and none of their sons (due to male-to-male transmission exclusion) ((GEN015)).
  • Y-Linked (Holandric) Inheritance: : Passed exclusively from father to son; only males are affected, and male-to-male transmission is observed ((GEN016)).
  • Mitochondrial Inheritance: : - Genome: Double-stranded circular DNA with 16,568 base pairs present in high copy numbers per cell ((GEN007)). - Transmission: Strictly maternal because sperm mitochondria are eliminated post-fertilization ((GEN018)). - Heteroplasmy: Coexistence of a mixture of normal and abnormal mitochondrial genomes within a single cell, determining phenotypic severity ((GEN019)).
  • Genomic Imprinting: : Epigenetic silencing (via DNA methylation or histone modification) of one parental allele based on the parent of origin, rendering the individual functionally hemizygous for that gene ((GEN020)).
  • Hardy-Weinberg Equilibrium: : Formula ($p^2 + 2pq + q^2 = 1$) used to predict carrier frequency ($2pq$) and genotype distribution in autosomal recessive populations ((GEN013)).
  • Multifactorial Inheritance: : Results from polygenic and environmental interactions; recurrence risk increases with disease severity and the number of affected relatives ((GEN021)). ---

Prenatal Screening, Counseling & Ethics

  • Prenatal Screening: : Routinely offered for trisomy 13, 18, and Down syndrome via maternal serum screening, ultrasound, or cell-free fetal DNA ((GEN005)). - Timelines: Chorionic villus sampling (CVS) is performed at 10–12 weeks, while amniocentesis is performed later ((GEN005)).
  • Genetic Counseling Principles: : Core elements include pedigree collection, risk assessment, and psychosocial support. Making definitive diagnostic or management decisions on behalf of the family is **contraindicated** due to the principle of non-directiveness and patient autonomy ((GEN026)).
  • Indications for Counseling: : Advanced maternal age ($\ge$35 years), history of congenital anomaly, or family history of genetic/metabolic disorders. A normal first-trimester screen is **not** an indication ((GEN027)).
  • Ethical & Legal Safeguards: : - Genetic testing must be performed confidentially ((GEN006)). - GINA (2008): Protects against genetic discrimination by employers and health insurers, but does **not** extend to life, disability, or long-term care insurance ((GEN006)).
  • Epidemiology: : 47,XXY (Klinefelter syndrome) is the most common chromosomal abnormality in newborns (approx. 1 in 1,000 live male births) ((GEN033)). ---

Therapeutics & Pharmacogenetics

  • Pediatric Pharmacogenetics: : Studies how genetic polymorphisms (e.g., TPMT in thiopurines, CYP2D6 in codeine) influence a child's drug metabolism, efficacy, and toxicity ((GEN025)).
  • Physiologic Therapies: : Modulate the physiologic effects of genetic blocks without replacing genes (e.g., dietary phenylalanine restriction in PKU or biotin supplementation) ((GEN028)).
  • Enzyme Replacement Therapy (ERT): : Utilizes mannose-6-phosphate-tagged enzymes targeted to lysosomes for storage disorders (e.g., Gaucher, Fabry, Pompe, MPS) ((GEN029)).
  • Ex Vivo Gene Therapy: : Patient cells are harvested, genetically corrected outside the body, and reinfused (e.g., CAR T-cell therapies) ((GEN030)). - Distractor: In vivo therapy involves direct systemic or localized vector injection into the patient ((GEN030)).
  • Gene Editing: : Employs nucleases (ZFNs, TALENs, CRISPR/Cas9) to introduce double-strand breaks corrected via nonhomologous end joining or homology-directed repair ((GEN031)).
  • Spinal Muscular Atrophy (SMA) Therapies: :
  • Nusinersen: : Antisense oligonucleotide (ASO) targeting SMN2, administered intrathecally ((GEN032)). - Distractor: Onasemnogene abeparvovec is an AAV vector-based gene therapy administered intravenously ((GEN032)).

Principles of Genetics, Aneuploidy, & Cytogenetics

  • Aneuploidy Etiology: ((GEN036)): The most common cause of aneuploidy is meiotic nondisjunction (failure of chromosomes to disjoin during meiosis I or II), leading to abnormal gamete chromosome numbers. Mitotic nondisjunction can post-zygotically produce mosaicism, but is not the primary cause.
  • Trisomy 16 Characteristics: ((GEN039)): Trisomy 16 is the most commonly observed autosomal aneuploidy in spontaneous abortions, is generally incompatible with postnatal survival, and has a negligible recurrence risk (unlike maternal-age-related nondisjunctions). It is not a viable trisomy.
  • Reciprocal Translocation Mechanics: ((GEN037)): Involves breaks in nonhomologous chromosomes with reciprocal segment exchange. Carriers are usually phenotypically normal but face high risk for unbalanced gametes and miscarriages. Contrast with Robertsonian translocations which involve fusion of long arms of two acrocentric chromosomes (13, 14, 15, 21, 22) ((GEN037)).
  • Pallister-Killian Syndrome: ((GEN038)): Caused by mosaic tetrasomy of chromosome 12p (supernumerary isochromosome i(12p)), presenting with coarse facies, generalized hypotonia, sparse scalp hair, and pigmentary skin anomalies.
  • Down Syndrome Classification: ((GEN040)): Down syndrome (Trisomy 21) results from meiotic nondisjunction and is a chromosomal aneuploidy, not an imprinting disorder.

Genomic Imprinting & Microdeletion Syndromes

  • Prader-Willi Syndrome (PWS) Criteria & Phases: ((((GEN041)) · ((GEN056)) · ((GEN065)))): - Major criteria include neonatal/infantile hypotonia, early feeding difficulties/failure to thrive, and hyperphagia/obesity developing between 1–6 years. Short stature for family by 15 years is a minor criterion ((GEN041)). - Etiology: Can be caused by paternal 15q11-q13 deletion, or uniparental disomy (UPD) where both copies of chromosome 15 are maternally inherited ((GEN056)). - Nutritional Evolution: Phase 1a (0–9 mo) features hypotonia and poor feeding; Phase 2b (4.5–8 years) marks the onset of increased appetite and hyperphagia ((GEN065)).
  • 22q11 Deletion Syndrome: ((GEN042)): Encompasses DiGeorge and Velocardiofacial syndromes resulting from 3rd/4th pharyngeal pouch defects. Hallmarks: cleft palate, congenital heart disease (conotruncal), hypocalcemia (parathyroid hypoplasia), and T-cell/immunoglobulin deficiency (thymic hypoplasia). Contrast with Williams syndrome (7q11 deletion: supravalvular aortic stenosis, friendly personality) and Miller-Dieker syndrome (17p13 deletion: lissencephaly, microcephaly, seizures).
  • Trisomy 13 (Patau Syndrome): ((GEN062)): Characterized by midline cleft lip/palate, postaxial polydactyly, holoprosencephaly, ocular hypotelorism, and severe early lethality (median survival ~12 days).
  • Cri du Chat Syndrome: ((GEN063)): Caused by terminal deletion of the short arm of chromosome 5 (5p−). Features a distinctive high-pitched, cat-like cry in early infancy due to laryngeal hypoplasia, alongside microcephaly and severe intellectual disability. Contrast with Wolf-Hirschhorn syndrome (4p− deletion, "Greek helmet" facies).

Ciliopathies, Rasopathies, & Developmental Sequences

  • Ciliopathy Spectrum: ((((GEN043)) · ((GEN069)))): Bardet-Biedl syndrome is a primary sensory ciliopathy presenting with central obesity, postaxial polydactyly, retinal dystrophy/retinitis pigmentosa, and renal dysfunction (((GEN043)) · ((GEN069))). Wilson disease is a copper metabolism defect (ATP7B) and not a ciliopathy ((GEN043)).
  • Rasopathies: ((((GEN044)) · ((GEN068)))): Caused by dysregulated RAS/MAPK signaling. Includes Noonan syndrome, Neurofibromatosis type 1, Costello syndrome, and Legius syndrome (SPRED1 gene mutation), the latter of which mimics NF1 via café-au-lait macules and axillary freckling but lacks neurofibromas, optic gliomas, or Lisch nodules (((GEN044)) · ((GEN068))).
  • Pierre Robin Sequence: ((((GEN05)) · ((GEN066)))): A classic sequence defined as multiple anomalies cascading from a single primary defect: mandibular hypoplasia leads to glossoptosis, preventing palatal shelf closure and causing a U-shaped cleft palate ((GEN045)). Contrast with malformations like Fetal Alcohol Syndrome (direct teratogenic insult causing short palpebral fissures, smooth philtrum, and thin upper lip) ((GEN066)).
  • VACTERL Association & NAD Deficiency: ((GEN067)): Biallelic variants in kynurenine pathway genes (KYNU, HAAO) disrupt de novo NAD biosynthesis, causing vertebral, anal, cardiac, and radial limb defects overlapping with VACTERL association.

Skeletal Dysplasias, Chromosomal Instability, & Complex Inheritance

  • Leri-Weill Dyschondrosteosis: ((GEN054)): Caused by heterozygous pathogenic variants in the SHOX gene located in the pseudoautosomal region (PAR1) of X and Y chromosomes, resulting in an autosomal-appearing inheritance pattern despite sex-chromosome linkage.
  • Fragile X Syndrome & Anticipation: ((GEN055)): Caused by triplet repeat expansion (CGG) in the 5'-UTR of the FMR1 gene (Xq27.3). Hypermethylation leads to deficiency of FMRP (Fragile X Mental Retardation Protein), presenting with intellectual disability, macroorchidism, and characteristic facies.
  • Chromosomal Instability Syndromes: ((GEN064)): Bloom syndrome (RECQL3 pathogenic variant) features proportionate growth restriction, photosensitive butterfly facial rash, immunodeficiency, and marked sister chromatid exchange on cytogenetics.
  • Apert Syndrome: ((GEN070)): Caused by activating mutations in the FGFR2 gene, characterized by craniosynostosis (coronal), midface hypoplasia, and symmetric syndactyly ("mitten hand").

Pharmacogenetics, Genetic Testing Modalities, & Therapies

  • Predictive and Predispositional Genetic Testing: ((((GEN046)) · ((GEN047)) · ((GEN058)))): Performed in asymptomatic individuals with family history (e.g., BRCA1/2, APC, familial hypercholesterolemia via LDL receptor mutations) to guide early preventive measures and surveillance (((GEN047)) · ((GEN058))).
  • Pharmacogenetics: *NAT2* Polymorphism: ((GEN059)): Patients with homozygous "slow acetylator" variants of the NAT2 gene exhibit decreased acetylation of isoniazid, predisposing them to drug-induced hepatitis and peripheral neuropathy.
  • Genetic Testing Selection Strategy: ((((GEN049)) · ((GEN050)) · ((DN052)))): - Single-gene disorders with minimal locus heterogeneity (e.g., CFTR in cystic fibrosis): Single-gene sequencing ((GEN052)). - Conditions caused by multiple candidate genes (e.g., muscular dystrophies): Gene panel sequencing ((GEN049)). - Multisystem or suspected mitochondrial disorders / critically ill neonates: Whole genome sequencing ((GEN050)).
  • Advanced Therapeutics & Gene Therapy: ((((GEN060)) · ((GEN061)))):
  • Nusinersen: : Antisense oligonucleotide (ASO) enhancing SMN2 exon 7 inclusion for SMA; must be delivered intrathecally due to the blood-brain barrier ((GEN060)).
  • Valoctocogene roxaparvovec: : AAV5-based in vivo gene transfer delivering a functional F8 gene to hepatocytes for Hemophilia A ((GEN061)).

Congenital Malformations, Dysmorphic Syndromes & Teratogenesis

  • Smith–Lemli–Opitz Syndrome (SLOS): ((GEN071)): Caused by defective cholesterol biosynthesis due to mutations in the DHCR7 gene (7-dehydrocholesterol reductase). Impaired cholesterol production leads to reduced Sonic Hedgehog (SHH) signaling. Diagnostic hallmarks: Microcephaly, anteverted nose tip, ptosis, syndactyly of the 2nd and 3rd toes, ambiguous genitalia, and growth retardation. (Distractor contrast: Meckel–Gruber syndrome is a ciliopathy presenting with occipital encephalocele, cystic kidneys, and postaxial polydactyly).
  • Holoprosencephaly: ((GEN092)): A developmental field defect from failed cleavage of the prosencephalon during the 3rd–4th week of embryogenesis, driven by defective Sonic Hedgehog (SHH) (ZIC2, SIX3, TGIF) signaling pathways. Spans from alobar (cyclopia, proboscis) to microforms (single maxillary incisor, midline cleft lip/palate). Frequently linked with trisomy 13 (Patau syndrome).
  • Mechanisms of Structural Birth Defects: ((((GEN084)) · ((GEN085)))):
  • Deformation: ((GEN084)): Extrinsic mechanical forces acting on normally developing tissue (e.g., breech deformation sequence from oligohydramnios causing hip dislocation, clubfoot, and cranial flattening; completely reversible postnatally).
  • Disruption: ((GEN085)): Secondary destruction of an originally normal structure via extrinsic forces, such as amniotic band entrapment causing fibrous strangulation, asymmetric limb/digit amputations, and distal swelling. - Malformation: Intrinsic genetic/developmental tissue defect. Dysplasia: Abnormal cellular organization within tissue. ---

Chromosomal Disorders & Microdeletions

  • Down Syndrome (Trisomy 21): ((GEN098)): Diagnosed rapidly via Fluorescence in situ hybridization (FISH) using chromosome 21-specific DNA probes on interphase cells, revealing three distinct fluorescent signals.
  • Turner Syndrome: ((GEN082)): Complete or partial loss of an X chromosome (45,X). Features short stature (from SHOX haploinsufficiency), webbed neck, low posterior hairline, shield chest with widely spaced nipples, cubitus valgus, streak gonads, and coarctation of the aorta.
  • Klinefelter Syndrome: ((GEN073)): The most common cause of primary hypogonadism and male infertility, characterized by the 47,XXY karyotype (nondisjunction, frequently paternal). Features tall eunuchoid stature, small firm testes, gynecomastia, and hypergonadotropic hypogonadism (low testosterone, elevated FSH/LH).
  • Prader–Willi Syndrome (PWS) vs. Angelman Syndrome (AS): ((((GEN081)) · ((GEN083)))): Genomic imprinting disorders of chromosome 15q11–q13.
  • Prader–Willi Syndrome: ((GEN083)): Caused by loss of paternal gene expression via paternal microdeletion (~70%) or maternal uniparental disomy (~30%). Features neonatal hypotonia, almond-shaped eyes, small hands/feet, and hyperphagia/obesity.
  • Angelman Syndrome: ((GEN081)): Caused by loss of maternal contribution (UBE3A gene inactivation) via maternal deletion. Features frequent unprovoked laughter, seizures, ataxia, and a "happy puppet" facies.
  • Williams Syndrome: ((GEN080)): Microdeletion at 7q11.23 encompassing the ELN (elastin) gene. Features "elfin" facies, cocktail-party (friendly) personality, hypercalcemia, and supravalvular aortic stenosis.
  • DiGeorge / Velocardiofacial Syndrome: ((GEN100)): Microdeletion at 22q11.2 involving the TBX1 gene. Characterized by conotruncal cardiac defects (tetralogy of Fallot, interrupted aortic arch), thymic hypoplasia (immunodeficiency), parathyroid hypoplasia (hypocalcemia), and cleft palate. ---

Chromosomal Rearrangements & Cytogenetics

  • Robertsonian Translocation: ((GEN099)): Fusion of long (q) arms of two acrocentric chromosomes (13, 14, 15, 21, 22) at the centromere with loss of short (p) arms. Carriers possess 45 chromosomes and are phenotypically normal (balanced), but carry high risk for miscarriage or unbalanced progeny (e.g., translocation Down syndrome).
  • Craniosynostosis & Skull Sutures: ((GEN087)): Brachycephaly (shortened anteroposterior diameter, wide biparietal width) results from premature fusion of bilateral coronal sutures (bicoronal synostosis), often seen in syndromic craniosynostoses (FGFR2/FGFR3 mutations). Sagittal suture fusion causes scaphocephaly (dolichocephaly). ---

Mendelian Inheritance Patterns & Genetic Phenomena

  • Pseudodominant Inheritance: ((GEN077)): Occurs when an autosomal recessive disorder mimics dominant transmission because an affected homozygous individual mates with a heterozygous carrier (e.g., nonsyndromic hearing loss via the GJB2 gene/connexin 26), yielding a 50% recurrence risk in each generation.
  • Genetic Anticipation: ((GEN078)): Progressive increase in severity and earlier onset of a disorder across successive generations due to expanding trinucleotide repeat mutations (e.g., CTG repeats in the DMPK gene causing Myotonic Dystrophy Type 1).
  • Y-Linked (Holandric) Inheritance: ((GEN094)): Trait transmission exclusively from father to son via the Y chromosome (e.g., AZF microdeletions causing male infertility/azoospermia, SRY mutations). Features vertical transmission among males only and zero female carriers.
  • Penetrance & Expression: ((GEN093)): Incomplete penetrance describes individuals carrying a pathogenic variant who manifest zero clinical signs of the condition (e.g., unaffected obligate carriers in APC-associated familial adenomatous polyposis). ---

Molecular Genetics, Genomics & Therapeutics

  • Hypertrophic Cardiomyopathy (HCM) Testing: ((GEN072)): Due to high locus heterogeneity (sarcomeric genes like MYH7 and MYBPC3), the mandatory diagnostic strategy is targeted cardiomyopathy gene panel sequencing rather than single-gene sequencing or whole exome/genome sequencing.
  • Microarray vs. Other Assays: ((((GEN074)) · ((GEN079)))):
  • Microarray analysis: ((GEN074)) hybridizes fluorescently labeled cDNA from two tissue samples onto thousands of DNA probes to profile genome-wide gene expression simultaneously.
  • Linkage analysis: ((GEN079)) tracks polymorphic DNA markers near a disease locus within families to determine fetal carrier/affected status when the exact mutation remains uncharacterized.
  • Gene Editing vs. Gene Therapy Platforms: ((((GEN095)) · ((GEN096)))):
  • Gene Editing: ((GEN095)): Employs nucleases (CRISPR/Cas9) to induce double-strand DNA breaks corrected via homology-directed repair with a donor template.
  • DNA-based Gene Therapy: ((GEN096)): Utilizes viral vectors (Adeno-associated virus - AAV) to deliver functional genes long-term (e.g., micro-dystrophin for Duchenne muscular dystrophy, SMN1 for spinal muscular atrophy).
  • RNA-based Therapy: ((GEN096)): Employs antisense oligonucleotides (ASOs) like nusinersen to modulate post-transcriptional RNA splicing. ---

Chromatin Remodeling, Transcription Regulators & Skeletal Dysplasias

  • Kabuki Syndrome: ((GEN088)): Chromatin regulatory disorder caused by pathogenic variants in KMT2D (autosomal dominant) or KDM6A (X-linked). Features long palpebral fissures, everted lower eyelids, arched eyebrows with sparse lateral thirds, and persistent fetal finger pads.
  • Rubinstein–Taybi Syndrome: ((GEN089)): Caused by mutations in histone acetyltransferase genes CREBBP or EP300. Features broad thumbs and great toes, beaked nose with grimacing smile, and congenital heart defects.
  • Cornelia de Lange Syndrome (CdLS): ((GEN090)): A cohesinopathy caused by variants in NIPBL, SMC1A, or SMC3. Features synophrys (unibrow), long eyelashes, thin lips, microcephaly, and upper limb reduction defects.
  • Coffin–Siris Syndrome: ((GEN091)): Caused by SWI/SNF chromatin remodeling complex gene variants (SMARCA4, ARID1B, SMARCB1). Features coarse facies, thick eyebrows, hypertrichosis, and hypoplastic/absent fifth fingernails and distal phalanges.
  • Noonan Syndrome: ((GEN086)): A RASopathy driven by gain-of-function variants activating the PTPN11 gene (encodes SHP2) within the RAS/MAPK pathway. Features hypertelorism, down-slanting palpebral fissures, webbed neck, pectus excavatum, and pulmonary valve stenosis.
  • Campomelic Dysplasia: ((GEN101)): A lethal skeletal dysplasia caused by heterozygous pathogenic variants or deletions in the SOX9 gene (chromosome 17q24). Features short limbs with bowing (campomelia) of femora and tibiae, hypoplastic scapulae, a narrow thoracic cage causing neonatal respiratory distress, and 46,XY sex reversal (ambiguous/female external genitalia).